313 related articles for article (PubMed ID: 17608509)
21. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
[TBL] [Abstract][Full Text] [Related]
22. [Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model].
Yang JL; Klinkebiel D; Boland MJ; Tang L; Christman JK
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):253-8. PubMed ID: 17706117
[TBL] [Abstract][Full Text] [Related]
23. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer.
Rangiah K; Tippornwong M; Sangar V; Austin D; Tétreault MP; Rustgi AK; Blair IA; Yu KH
J Proteome Res; 2009 Nov; 8(11):5153-64. PubMed ID: 19769411
[TBL] [Abstract][Full Text] [Related]
24. Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach.
Liu P; Kong L; Liang K; Wu Y; Jin H; Song B; Tan X
BMC Cancer; 2020 Jan; 20(1):45. PubMed ID: 31959150
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of acidic proteins with progression in the MCF10 model of human breast disease.
Buchanan NS; Zhao J; Zhu K; Patwa TH; Miller FR; Lubman DM
Int J Oncol; 2007 Oct; 31(4):941-9. PubMed ID: 17786328
[TBL] [Abstract][Full Text] [Related]
26. Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model.
Kreunin P; Yoo C; Urquidi V; Lubman DM; Goodison S
Proteomics; 2007 Jan; 7(2):299-312. PubMed ID: 17205601
[TBL] [Abstract][Full Text] [Related]
27. Data-independent liquid chromatography/mass spectrometry (LC/MS(E)) detection and quantification of the secreted Apium graveolens pathogen defense protein mannitol dehydrogenase.
Blackburn K; Cheng FY; Williamson JD; Goshe MB
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1009-16. PubMed ID: 20213632
[TBL] [Abstract][Full Text] [Related]
28. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers.
Risha Y; Minic Z; Ghobadloo SM; Berezovski MV
Sci Rep; 2020 Aug; 10(1):13572. PubMed ID: 32782317
[TBL] [Abstract][Full Text] [Related]
29. Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue.
Röwer C; Vissers JP; Koy C; Kipping M; Hecker M; Reimer T; Gerber B; Thiesen HJ; Glocker MO
Anal Bioanal Chem; 2009 Dec; 395(8):2443-56. PubMed ID: 19876624
[TBL] [Abstract][Full Text] [Related]
30. Proteomic profiling of ovarian cancer models using TMT-LC-MS/MS.
Sinclair J; Timms JF
Methods Mol Biol; 2013; 1049():271-84. PubMed ID: 23913223
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of protein patterns of human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines.
Flodrova D; Toporova L; Macejova D; Lastovickova M; Brtko J; Bobalova J
Gen Physiol Biophys; 2016 Jul; 35(3):387-92. PubMed ID: 27174898
[TBL] [Abstract][Full Text] [Related]
32. Secretome analysis using a hollow fiber culture system for cancer biomarker discovery.
Chiu KH; Chang YH; Liao PC
Biochim Biophys Acta; 2013 Nov; 1834(11):2285-92. PubMed ID: 23376430
[TBL] [Abstract][Full Text] [Related]
33. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation.
Sarvaiya HA; Yoon JH; Lazar IM
Rapid Commun Mass Spectrom; 2006; 20(20):3039-55. PubMed ID: 16986208
[TBL] [Abstract][Full Text] [Related]
34. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer.
Loei H; Tan HT; Lim TK; Lim KH; So JB; Yeoh KG; Chung MC
J Proteome Res; 2012 Mar; 11(3):1759-72. PubMed ID: 22204653
[TBL] [Abstract][Full Text] [Related]
35. Impact of cathepsin B on the interstitial fluid proteome of murine breast cancers.
Gomez-Auli A; Hillebrand LE; Biniossek ML; Peters C; Reinheckel T; Schilling O
Biochimie; 2016 Mar; 122():88-98. PubMed ID: 26455267
[TBL] [Abstract][Full Text] [Related]
36. Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer.
Xu X; Qiao M; Zhang Y; Jiang Y; Wei P; Yao J; Gu B; Wang Y; Lu J; Wang Z; Tang Z; Sun Y; Wu W; Shi Q
Proteomics; 2010 Apr; 10(7):1374-90. PubMed ID: 20198662
[TBL] [Abstract][Full Text] [Related]
37. Sieving through the cancer secretome.
Lin Q; Tan HT; Lim HS; Chung MC
Biochim Biophys Acta; 2013 Nov; 1834(11):2360-71. PubMed ID: 23376431
[TBL] [Abstract][Full Text] [Related]
38. A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery.
Sjöström M; Ossola R; Breslin T; Rinner O; Malmström L; Schmidt A; Aebersold R; Malmström J; Niméus E
J Proteome Res; 2015 Jul; 14(7):2807-18. PubMed ID: 25944384
[TBL] [Abstract][Full Text] [Related]
39. Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.
Hurst DR; Xie Y; Edmonds MD; Welch DR
Clin Exp Metastasis; 2009; 26(2):89-96. PubMed ID: 18841483
[TBL] [Abstract][Full Text] [Related]
40. LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system.
Lapek JD; McGrath JL; Ricke WA; Friedman AE
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():34-42. PubMed ID: 22425387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
